Evaluation of implants coated with recombinant human bone morphogenetic protein-2 and vacuum-dried using the critical-size supraalveolar peri-implant defect model in dogs

Journal of Periodontology

Volumn 81, Issue 12, 2010, Pages 1839-1849

  Decker, John F ^a,b   Lee, Jaebum ^a   COrtella, Carlo Alberto ^a,c,d   Polimeni, Giuseppe ^a,c   Rohrer, Michael D ^e   Wozney, John M ^c   Hall, Jan ^f   Susin, Cristiano ^a   Wikesjö, Ulf M E ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b US Army Advanced Education Program in Periodontics   (United States)

^c San Raffaele Hospital ^*

^d SAN RAFFAELE HOSPITAL   (Italy)

^e UNIVERSITY OF MINNESOTA   (United States)

^f Nobelbiocare AB   (Sweden)

Author keywords

Bone density; Dental implants; Osseointegration; Osteogenesis; Recombinant; RhBMP 2 protein; Tissue engineering

Indexed keywords

EID: 78650093313     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2010.100220     Document Type: Article

References (34)

1. Wikesjö UM, Qahash M, Huang YH, Xiropaidis AV, Polimeni G, Susin C. Bone morphogenetic proteins for periodontal and alveolar indications: Biological observations-clinical implications. Orthod Craniofac Res 2009;12:263-270.
2. Hall J, Lausmaa J. Properties of a new porous oxide surface on titanium implants. Appl Osseoint Res 2000; 1:5-8.
3. Hall J, Sorensen RG, Wozney JM, Wikesjö UM. Bone formation at rhBMP-2 coated titanium implants in the rat ectopic model. J Clin Periodontol 2007;34:444-451.
4. Wikesjö UM, Xiropaidis AV, Qahash M, et al. Bone formation at recombinant human bone morphogenetic protein-2 coated titanium implants in the posterior mandible (Type II bone) in dogs. J Clin Periodontol 2008;35:985-991.
5. Wikesjö UM, Huang YH, Xiropaidis AV, et al. Bone formation at human bone morphogenetic protein-2 coated titanium implants in the posterior maxilla (Type IV bone) in nonhuman primates. J Clin Periodontol 2008;35:992-1000.
6. Wikesjö UM, Qahash M, Polimeni G, et al. Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-2 (rhBMP-2): Histologic observations. J Clin Periodontol 2008;35:1001-1010.
7. Susin C, Qahash M, Polimeni G, et al. Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-7 (rhBMP-7/rhOP-1): Histological observations. J Clin Periodontol 2010;37:574-581.
8. Polimeni G, Wikesjö UM, Susin C, et al. Alveolar ridge augmentation using implants coated with recombinant human growth/differentiation factor-5: Histologic observations. J Clin Periodontol 2010;37:759-768.
9. Leknes KN, Yang J, Qahash M, Polimeni G, Susin C, Wikesjö UM. Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-2: Radiographic observations. Clin Oral Implants Res 2008;19:1027-1033.
10. Leknes KN, Yang J, Qahash M, Polimeni G, Susin C, Wikesjö UM. Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-7 (rhBMP-7/rhOP-1). Radiographic observations. J Clin Periodontol 2008;35:914-919.
11. Wikesjö UM, Susin C, Qahash M, et al. The criticalsize supraalveolar peri-implant defect model: Characteristics and use. J Clin Periodontol 2006;33:846-854.
12. Hageman MJ. Water sorption and solid-state stability of proteins. In: Ahern TJ, Manning MC, eds. Stability of Protein Pharmaceuticals. Part A: Chemical and Physical Pathways of Protein Degradation. New York: Plenum Press; 1992:273-309.
13. Mattern M, Winter G, Kohnert U, Lee G. Formulation of proteins in vacuum-dried glasses. II. Process and storage stability in sugar-free amino acid systems. Pharm Dev Technol 1999;4:199-208.
14. Sharma VK, Kalonia DS. Polyethylene glycol-induced precipitation of interferon alpha-2a followed by vacuum drying: Development of a novel process for obtaining a dry, stable powder. AAPS J 2004;6:31-44.
15. Lee J, Decker JF, Polimeni G, et al. Evaluation of implants coated with rhBMP-2 using two different coating strategies: A critical-size supraalveolar periimplant defect study in dogs. J Clin Periodontol 2010;37:582-590.
16. Li XJ, Jee WS. Integrated bone tissue anatomy and physiology. In: Deng HW, Liu YZ, Guo CY, Chen D, eds. Current Topics in Bone Biology. Singapore: World Scientific Publishing Company; 2005:11-56.
17. Donath K, Breuner G. A method for the study of undecalcified bones and teeth with attached soft tissues. The Sage-Schliff (sawing and grinding) technique. J Oral Pathol 1982;11:318-326.
18. Rohrer MD, Schubert CC. The cutting-grinding technique for histologic preparation of undecalcified bone and bone-anchored implants. Improvements in instrumentation and procedures. Oral Surg Oral Med Oral Pathol 1992;74:73-78.
19. Barnhart HX, Haber MJ, Lin LI. An overview on assessing agreement with continuous measurements. J Biopharm Stat 2007;17:529-567.
20. Tatakis DN, Koh A, Jin L, Wozney JM, Rohrer MD, Wikesjö UM. Peri-implant bone regeneration using recombinant human bone morphogenetic protein-2 in a canine model: A dose-response study. J Periodontal Res 2002;37:93-100.
21. Wikesjö UM, Qahash M, Thomson RC, et al. Spaceproviding expanded polytetrafluoroethylene devices define alveolar augmentation at dental implants induced by recombinant human bone morphogenetic protein 2 in an absorbable collagen sponge carrier. Clin Implant Dent Relat Res 2003;5:112-123.
22. Qahash M, Hardwick WR, Rohrer MD, Wozney JM, Wikesjö UM. Surface-etching enhances titanium implant osseointegration in newly formed (rhBMP-2-induced) and native bone. Int J Oral Maxillofac Implants 2007;22:472-477.
23. Polimeni G, Koo KT, Qahash M, Xiropaidis AV, Albandar JM, Wikesjö UM. Prognostic factors for alveolar regeneration: Bone formation at teeth and titanium implants. J Clin Periodontol 2004;31:927-932.
24. Polimeni G, Koo KT, Qahash M, Xiropaidis AV, Albandar JM, Wikesjö UM. Prognostic factors for alveolar regeneration: Effect of tissue occlusion on alveolar bone regeneration with guided tissue regeneration. J Clin Periodontol 2004;31:730-735. (Pubitemid 39186426)
25. Polimeni G, Albandar JM, Wikesjö UM. Prognostic factors for alveolar regeneration: Osteogenic potential of resident bone. J Clin Periodontol 2004;31:840-844. (Pubitemid 39387413)
26. Polimeni G, Albandar JM, Wikesjö UM. Prognostic factors for alveolar regeneration: Effect of space provision. J Clin Periodontol 2005;32:951-954.
27. Hunt DR, Jovanovic SA, Wikesjö UM, Wozney JM, Bernard GW. Hyaluronan supports recombinant human bone morphogenetic protein-2 induced bone reconstruction of advanced alveolar ridge defects in dogs. A pilot study. J Periodontol 2001;72:651-658.
28. Sigurdsson TJ, Nguyen S, Wikesjö UM. Alveolar ridge augmentation with rhBMP-2 and bone-to-implant contact in induced bone. Int J Periodontics Restorative Dent 2001;21:461-473.
29. Jovanovic SA, Hunt DR, Bernard GW, et al. Long-term functional loading of dental implants in rhBMP-2 induced bone. A histologic study in the canine ridge augmentation model. Clin Oral Implants Res 2003;14:793-803.
30. Jovanovic SA, Hunt DR, Bernard GW, Spiekermann H, Wozney JM, Wikesjö UM. Bone reconstruction following implantation of rhBMP-2 and guided bone regeneration in canine alveolar ridge defects. Clin Oral Implants Res 2007;18:224-230.
31. Towns JK. Moisture content in proteins: Its effects and measurement. J Chromatogr A 1995;705:115-127.
32. Wang W. Lyophilization and development of solid protein pharmaceuticals. Int J Pharm 2000;203:1-60.
33. Hsu CC, Ward CA, Pearlman R, Nguyen HM, Yeung DA, Curley JG. Determining the optimum residual moisture in lyophilized protein pharmaceuticals. Dev Biol Stand 1992;74:255-270; discussion 271.
34. Maa YF, Nguyen PA, Andya JD, et al. Effect of spray drying and subsequent processing conditions on residual moisture content and physical/biochemical stability of protein inhalation powders. Pharm Res 1998;15:768-775.